Correlation Between GeneFerm Biotechnology and Orient Pharma

Can any of the company-specific risk be diversified away by investing in both GeneFerm Biotechnology and Orient Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneFerm Biotechnology and Orient Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GeneFerm Biotechnology Co and Orient Pharma Co, you can compare the effects of market volatilities on GeneFerm Biotechnology and Orient Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneFerm Biotechnology with a short position of Orient Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneFerm Biotechnology and Orient Pharma.

Diversification Opportunities for GeneFerm Biotechnology and Orient Pharma

-0.33

Correlation Coefficient

GeneFerm Biotechnology  Orient Pharma

Very good diversification

The 3 months correlation between GeneFerm and Orient is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding GeneFerm Biotechnology Co and Orient Pharma Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orient Pharma and GeneFerm Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneFerm Biotechnology Co are associated (or correlated) with Orient Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orient Pharma has no effect on the direction of GeneFerm Biotechnology i.e., GeneFerm Biotechnology and Orient Pharma go up and down completely randomly.

Pair Corralation between GeneFerm Biotechnology and Orient Pharma

Assuming the 90 days trading horizon GeneFerm Biotechnology Co is expected to under-perform the Orient Pharma. But the stock apears to be less risky and, when comparing its historical volatility, GeneFerm Biotechnology Co is 2.38 times less risky than Orient Pharma. The stock trades about -0.28 of its potential returns per unit of risk. The Orient Pharma Co is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  3,685  in Orient Pharma Co on October 8, 2024 and sell it today you would lose (30.00) from holding Orient Pharma Co or give up 0.81% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

GeneFerm Biotechnology Co  vs.  Orient Pharma Co

GeneFerm Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GeneFerm Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, GeneFerm Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Orient Pharma

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Orient Pharma Co are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Orient Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with GeneFerm Biotechnology and Orient Pharma

The main advantage of trading using opposite GeneFerm Biotechnology and Orient Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneFerm Biotechnology position performs unexpectedly, Orient Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orient Pharma will offset losses from the drop in Orient Pharma's long position.

The idea behind GeneFerm Biotechnology Co and Orient Pharma Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.